Vascular Biogenics Ltd. Uncategorized Contracts & Agreements
8 Contracts & Agreements
- Engagement Letter by and between Notable Labs, Inc. and Scott A. McPherson dated March 1, 2023 (Filed With SEC on May 11, 2023)
- Co-Development and Profit-Sharing Agreement between Notable Labs, Inc. and CicloMed LLC dated July 20, 2021 (Filed With SEC on May 11, 2023)
- Side Letter by and between Boehringer Ingelheim International GmbH and Oncoheroes Biosciences Inc. dated August 1, 2019, as amended by Amendment #1 effective on April 5, 2020 (Filed With SEC on May 11, 2023)
- Form of Lock-Up Agreement, by and among Notable Labs, Inc., Vascular Biogenics Ltd., and certain directors and officers of Vascular Biogenics Ltd (Filed With SEC on May 11, 2023)
- Form of Lock-Up Agreement, by and among Notable Labs, Inc., Vascular Biogenics Ltd., and certain directors and officers of Notable Labs, Inc (Filed With SEC on May 11, 2023)
- Form of Support Agreement, by and between Vascular Biogenics Ltd., Notable Labs, Inc., and certain directors and officers of Vascular Biogenics Ltd (Filed With SEC on May 11, 2023)
- Form of Support Agreement, by and between Vascular Biogenics Ltd. and Notable Labs, Inc. and certain directors and officers of Notable Labs, Inc (Filed With SEC on May 11, 2023)
- Description of Securities (Filed With SEC on March 14, 2023)
